Compare Bioavailability of RO7239361 After Subcutaneous Injection

Completed · Phase 1

Conditions studied: Healthy

In brief

Randomized study in healthy men and women. Assess the similarity of RO7239361 when injected into the arm, thigh, or the stomach. Collect data on safety of RO7239361.

Key facts

Study ID

NCT03100630

Run by

Hoffmann-La Roche

People needed

99

Starts

2017-05-09

Expected to finish

2017-10-17

Last updated by the study team

2019-08-07

Who can join

Age: 18 and older, up to 55. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Healthy participant as determined by no significant deviations in normal medical and surgical history and assessments
• Body Mass Index 18 kg/m2 to 32 kg/m2
• females must be of non-childbearing potential

You may not qualify if…

• tattoos or other skin findings on any of the potential injection sites
• history of chronic muscle pain within 30 days prior to study treatment
• prior history of IgG1 therapy
• Other protocol defined inclusion and exclusion criteria apply

Where it is running

• WCCT Global, Inc. — Cypress, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.